Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study-Reference-Cited by-同舟云学术

Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study

Published:2024-06 Issue: Volume:185 Page:202-211
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Makker Vicky,Perez-Fidalgo Jose Alejandro,Valabrega Giorgio,Hamilton Erika,Van Gorp Toon,Sehouli Jalid,Regináčová Klaudia,Richardson Debra L.,Perri Tamar,Oza Amit M.,Miller David S.,Alía Eva Maria Guerra,De Giorgi Ugo,Henry Stephanie,Spitz Daniel L.,Wimberger Pauline,Bednaříková Markéta,Chon Hye Sook,Martínez-Garcia Jerónimo,Pisano Carmela,Berek Jonathan S.,Romero Ignacio,Scambia Giovanni,Fariñas-Madrid Lorena,Buscema Joseph,Schochter Fabienne,Li Kai,Kalyanapu Pratheek,Walker Christopher J.,Vergote Ignace

Funder

Karyopharm Therapeutics Inc

Publisher

Elsevier BV

Reference34 articles.

1. Endometrial cancer;Makker;Nat. Rev. Dis. Prim.,2021

2. Endometrial cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up;Oaknin;Ann. Oncol.,2022

3. Endometrial cancer: transitioning from histology to genomics;Mitric;Curr. Oncol.,2022

4. Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series;Kommoss;Ann. Oncol.,2018

5. A clinically applicable molecular-based classification for endometrial cancers;Talhouk;Br. J. Cancer,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Locally advanced and metastatic endometrial cancer: Current and emerging therapies;Cancer Treatment Reviews;2024-09